Found a bug or want a feature? Verified reports earn free credits.
Log inSign up

Product & regulatory approvals

Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.

Window30 days90 days180 daysSizeAll sizesLarge capMid capSmall capProfitable only
SortMost recentBest 1-week reactionLargest first
12 companies · 71 filings in 30 days
CompanyWhy it’s here — the filingReaction 1d / 1w / 1mPriceMcapP/EROCERev YoY
Glenmark PharmaceuticalsPharmaceuticalsGlenmark's US arm launches Calcium Gluconate Injection in US market21 Aug 2026Regulatory Product Approval×3pending₹2,33365,834 Cr46.7vs 28.514.7%-37.6%
Anant RajResidential Commercial ProjectsAnant Raj gets RERA registration for Gurugram luxury housing project20 Aug 2026Regulatory Product Approvalpending₹63422,800 Cr38.1vs 22.310.2%+2.5%
Colgate PalmolivePersonal CareColgate PerioGard earns ISP Seal of Acceptance — first in India18 Aug 2026Regulatory Product Approvalpending₹1,91051,952 Cr38.4vs 38.2107.1%+5.0%
Acutaas ChemicalsPharmaceuticalsAcutaas gets govt ECMS incentive approval for Electrolyte Additives unit18 Aug 2026Regulatory Product Approval+1.0% — —₹3,21026,281 Cr62.6vs 28.527.5%+41.3%
Biocon Limited.PharmaceuticalsBiocon gets U.S. FDA nod for Yesintek autoinjector format18 Aug 2026Regulatory Product Approval×3+0.2% — —₹41366,866 Cr110.3vs 28.50.9%+5.2%
LupinPharmaceuticalsLupin gets US FDA approval for Pitolisant Tablets generic17 Aug 2026Regulatory Product Approval×4-0.1% — —₹2,2021.01 L Cr19.1vs 28.526.7%+6.1%
Zydus LifesciencesPharmaceuticalsZydus launches REVAHALE, India's first once-daily nebulised LAMA for COPD10 Aug 2026Regulatory Product Approval×2+7.2% -1.0% —₹1,1151.12 L Cr24.2vs 28.518.0%+23.9%
DelhiveryLogistics Solution ProviderRBI grants NBFC registration to Delhivery Financial Services subsidiary4 Aug 2026Regulatory Product Approval-0.9% -1.4% —₹45033,695 Cr333.4vs 16.11.2%+11.4%
Sun Pharmaceutical Ind LPharmaceuticalsSun Pharma gets Brazil approval to market semaglutide for diabetes29 Jul 2026Regulatory Product Approval×3-0.3% -2.4% —₹1,9024.56 L Cr37.6vs 28.517.5%+0.9%
Gland PharmaPharmaceuticalsGland Pharma gets USFDA approval for Sugammadex Injection, Day 1 launch29 Jul 2026Regulatory Product Approval+3.6% +6.1% —₹2,84846,924 Cr37.4vs 28.513.4%+17.2%
DR. Reddy S LaboratoriesPharmaceuticalsDr Reddy's confirms Thailand approval for gonorrhoea drug NUZOLVENCE29 Jul 2026Regulatory Product Approval+0.9% +3.0% —₹1,18098,530 Cr34.3vs 28.513.0%-14.5%
CiplaPharmaceuticalsCipla gets US FDA approval for Generic Advair Diskus27 Jul 2026Regulatory Product Approval+4.2% +4.4% —₹1,4381.16 L Cr47.2vs 28.514.7%-13.8%
How this list is built

A company appears when an NSE/BSE filing inside the last 30 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.

MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.